Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC1 | Q13547 | 1/20 | 0.54 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.54 |
| ▸ | IDO1 | P14902 | 2/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.51 |
| ▸ | MDM4 | O15151 | 2/20 | 0.51 |
| ▸ | TP53 | P04637 | 2/20 | 0.51 |
| ▸ | TNF | P01375 | 1/20 | 0.49 |
| ▸ | CASP3 | P42574 | 2/20 | 0.48 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.48 |
| ▸ | TDO2 | P48775 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13402442 | 1.00 | HDAC1 (0.54) | HDAC1HDAC2IDO1KMT2AMDM4 | |
| SCHEMBL28527138 | 1.00 | HDAC1 (0.54) | HDAC1HDAC2IDO1KMT2AMDM4 | |
| SCHEMBL11912033 | 1.00 | HDAC1 (0.54) | HDAC1HDAC2IDO1KMT2AMDM4 | |
| SCHEMBL31000548 | 1.00 | HDAC1 (0.54) | HDAC1HDAC2IDO1KMT2AMDM4 | |
| SCHEMBL29555721 | 0.91 | HDAC1 (0.57) | HDAC1HDAC2IDO1KMT2AMDM4 | |
| SCHEMBL377964 | 0.91 | HDAC1 (0.57) | HDAC1HDAC2IDO1KMT2AMDM4 | |
| SCHEMBL392598 | 0.91 | HDAC1 (0.57) | HDAC1HDAC2IDO1KMT2AMDM4 | |
| SCHEMBL15982313 | 0.91 | HDAC1 (0.57) | HDAC1HDAC2IDO1KMT2AMDM4 | |
| SCHEMBL16167663 | 0.90 | CTSK (0.47) | HDAC1HDAC2IDO1KMT2ATNF | |
| SCHEMBL18718108 | 0.90 | CASP3 (0.51) | HDAC1HDAC2IDO1KMT2AMDM4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250263365-A1 | O-SUBSTITUTED SERINE DERIVATIVE PRODUCTION METHOD | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2025-08-21 | — | — | US | disclosed |
| EP-3878836-B1 | O-SUBSTITUTED SERINE DERIVATIVE PRODUCTION METHOD | CHUGAI PHARMACEUTICAL CO LTD (JP) | 2025-07-23 | — | — | EP | disclosed |
| US-12312297-B2 | O-substituted serine derivative production method | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2025-05-27 | — | — | US | disclosed |
| EP-4425181-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTE | Bertis Inc (KR) | 2024-09-04 | — | — | EP | disclosed |
| CN-112969683-B | Process for the preparation of O-substituted serine derivatives | 中外制药株式会社 | 2024-05-14 | — | — | CN | disclosed |
| US-20240011979-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTES | BERTIS INC. (KR) | 2024-01-11 | — | — | US | disclosed |
| CN-116829949-A | Compositions for detecting or measuring analytes | 伯蒂斯有限公司 | 2023-09-29 | — | — | CN | disclosed |
| WO-2023075435-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTE | 주식회사 베르티스 | 2023-05-04 | — | — | WO | disclosed |
| US-20220283131-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTES | BERTIS CO., LTD. (KR) | 2022-09-08 | — | — | US | disclosed |
| WO-2022050529-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTE | ㈜베르티스 | 2022-03-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250263365-A1 | O-SUBSTITUTED SERINE DERIVATIVE PRODUCTION METHOD | STS, SMOX, TST | HDAC1 4027/4885HDAC2 4004/4885IDO1 1734/4885 |
| US-12312297-B2 | O-substituted serine derivative production method | STS, SMOX, TST | HDAC1 4027/4885HDAC2 4004/4885IDO1 1734/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.